Skip to content

English

繁體中文

syneuRx-logo
  • About
    • Mission
    • Leadership Team
    • Major Milestone
    • Contact
  • Service
    • New Drug Development
  • Research
    • Antiviral Platform
    • NMDA Platform
    • Pipeline
  • Trials
    • SNA11
    • SNG12
    • SND12
  • PRODUCT
  • Newsroom
    • Press Release
    • Publication
    • Media
  • About
    • Mission
    • Leadership Team
    • Major Milestone
    • Contact
  • Service
    • New Drug Development
  • Research
    • Antiviral Platform
    • NMDA Platform
    • Pipeline
  • Trials
    • SNA11
    • SNG12
    • SND12
  • PRODUCT
  • Newsroom
    • Press Release
    • Publication
    • Media

Press Release

ALL

2022

2021

2020~2015

Nov 19, 2021

SyneuRx Announces Oral COVID-19 Twindemic Antiviral Drug Candidate Pentarlandir Has Entered Final Portion of FDA Phase II Testing

Jun 23, 2021

SyneuRx Announces Closing of Public Offering

Jun 08, 2021

Taiwan FDA Approves SyneuRx’s IND Application for COVID-19 Clinical Trial

Jun 03, 2021

SyneuRx Files an IND Application for COVID-19 Clinical Trial in Taiwan SyneuRx Initiates Clinical Trial SNB01 Pentarlandir® For Covid-19

Apr 27, 2021

SyneuRx Initiates Clinical Trial SNB01 Pentarlandir® For Covid-19

Mar 26, 2021

US FDA Approves SyneuRx’s IND Application for a Phase II Clinical Trial for Adult Patients with Treatment-Resistant Depression and Suicidal Symptoms

Mar 08, 2021

TFDA Approves SyneuRx's Schizophrenia Trials in Taiwan as part of its Global Schizophrenia Trials

Feb 26, 2021

Ω-NaBen, the Ultimate and Supreme Sodium Benzoate

Feb 04, 2021

US FDA Approves SyneuRx’s IND Application for a First-in-Human, Proof of Principle Clinical Trial for Patients with Early and Mild COVID-19

Privacy Policy

Terms of Use

Contact

About

  • Mission
  • Leadership Team
  • Major Milestone

Research

  • Antiviral Platform
  • NMDA Platform
  • Pipeline

Trials

  • SNA11
  • SNG12
  • SND12

Newsroom

  • Press Release
  • Publication
  • Media
SyneuRx International (Taiwan) Corp.
Copyrights © 2013 SyneuRx Corp. All rights reserved.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.okPrivacy policy